Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...
The start-up’s launch network will focus on least two major European cities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback